Abstract
Adolescents and young people in Sub-Saharan Africa (SSA) face high mortality rates due to the Human Immunodeficiency Virus (HIV), highlighting the need for effective case identification strategies. The index testing strategy has shown promise, but its implementation and potential for use among this population remain poorly understood. We conducted a systematic review of the literature, searching multiple databases and repositories for studies conducted in SSA since 2010, involving individuals aged 10 to 24 years. Out of 1,448 studies initially identified, only three met the inclusion criteria. The implementation of the index testing strategy primarily involved recruiting index clients at healthcare facilities and testing points, followed by community-based testing. The involvement of community health workers and peer mentors proved valuable in achieving high yields. However, the legal age for consent poses a barrier to utilizing this strategy among adolescents and young people. By addressing barriers and improving facilitators, the index testing strategy holds great potential for effective case identification in this age group in SSA.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials
